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Abstract: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death 
according to the World Health Organization (WHO). Like any chronic disease, the clinical process 
of COPD affects the patient’s life. Currently, clinical processes are inefficient, causing a loss of 
quality of life for patients and a high economic increase in the costs borne by family members, health 
systems and society. This paper presents a new approach to the redesign of the process for the 
management of COPD based on the use of the strategy of continuous improvement Business Process 
Management. This approach aims to improve the efficiency of the management of chronic diseases 
such as COPD, while achieving a higher quality of life and patient satisfaction. 
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1. Introduction 
Chronic diseases constitute a major health problem for all health organizations worldwide. 
According to the World Health Organization (WHO) [1], chronic diseases are the leading cause of 
death in the world, representing 60% of deaths worldwide. Among these diseases we can find the 
chronic obstructive pulmonary disease (COPD), which, in accordance to the WHO, is in the third 
position of the list of leading causes of death, with 6%. COPD is a combination of different diseases 
related among them, whose main feature is the difficulty in the breathing process [2]. 
The global initiative for chronic obstructive lung disease describes the COPD as an avoidable 
and treatable disease with additional pulmonary effects which may contribute to the patient’s 
deterioration [3]. COPD is a complex disease which often presents a comorbidity associated to cancer, 
diabetes, high blood pressure and depression, among others [4]. Smoking is one of the main risk 
factors to suffer from COPD [3–5], although there are other factors which may also contribute to the 
development of the disease such as genes, age, sex, the lung’s growth, the exposure to particles [3,5] 
or recurrent respiratory diseases during childhood and bronchial hyperactivity [4]. 
As any chronic disease, the clinical process associated to COPD extends to the patient’s life. This 
fact, together with the management models currently used, make most clinical processes be 
inefficient, causing deterioration in the patient’s quality of life and a high increase in the costs 
incurred by their relatives, health systems and society in general [3,6–8]. 
Business Process Management (BPM) is one of the most recent strategies of process management 
and also the one that has a significant impact. It is focused on the continuous improvement of 
business processes using information technology as one of its main principles in processes execution 
[9]. So far, in health issues, it has mainly been applied to the improvement of administrative 
Proceedings 2018, 2, 1207 2 of 9 
 
processes. The proposal and novelty of this paper is focused on the application of a BPM model to 
the COPD clinical process, in order to reduce the problems associated to the current clinical process, 
with the specific goal of improving the patient’s quality of life while reducing the costs and errors 
related to that process. More specifically, we focus on the redesign of the current diagnosis process 
by implementing a new paradigm for the management of COPD. This paper is organized into 
sections as follows: Section 2 provides a brief review of related works. In Section 3, the Business 
Process Management strategy is explained. The COPD clinical process is described in Section 4. 
Section 5 addresses the main weaknesses in the COPD process. The redesign process is proposed in 
Section 6. In Section 7, Conclusion remarks are presented. Finally, future research lines and next steps 
are exposed in Section 8. 
2. Related Literature 
In order to treat COPD there currently exist many guidelines, both locally (Spain) and 
worldwide. Among all of them, we must highlight the one proposed by Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) [3]. In many countries, this guide has been taken as a reference to 
adapt the circumstances of each region and their health systems. A key factor when treating the 
disease as a global process is the use of information and communications technologies (ICTs), which 
everyday has a more important role in the clinical process, assisting both the medical staff and the 
patients to control their health for years. Next, we will see some ICTs applications to the clinical 
processes related to COPD. 
In [10] wireless mobile devices are used to communicate data with the spirometer, together with 
a website designed as a guide tool to support clinical decisions. Also, some decision support systems 
have been designed for teleassistance applications in COPD patients [11]. There are also 
telemonitoring solutions through mobile devices via Bluetooth [12]. 
On the other hand, in [13] we can see a proposal for a specific architecture for COPD patients, 
where a mobile device collects the data which are stored in a remote server and which can be 
consulted by medical staff, even making a video call if needed. This architecture also expects to 
prevent exacerbations in early stages. In [14] there is a study of the impact of mobile devices to treat 
COPD using a platform that interconnects devices, sensors, and medical centers through different 
communication protocols. All these aids are only partial solutions in the different sub-processes 
which make up the COPD clinical process. 
Business Process Management (BPM) is shown as a backbone element of the whole clinical 
process of the disease. Its advantages, which have already been applied in industrial and business 
areas, make it a suitable methodology for the health area, especially if we bear in mind the target of 
trying to reduce costs and improve the assistance quality. All the initiatives show the use of ICTs to 
assist in the diagnostic and treatment processes, but they are not managed by the process, which 
turns them, once again, in partial solutions to the clinical process. An integral solution through BPM 
of all the participating agents in a specific clinical process, in this case COPD, may make the whole 
process subject to a continuous improvement, providing enough flexibility when facing unexpected 
changes in process. It will make the parts of the process automatic, and it will mean higher savings 
in the health system expenditure and a noteworthy increase of the patient satisfaction. 
The main novelty of our paper lies in the use of business process and IT management strategies 
as well as the proposal of a comprehensive management framework for the entire process, which will 
allow its automatization. Thus, the disease is treated globally, with the process itself coordinating the 
actors and tasks involved in it. 
3. Business Process Management 
BPM is a strategy oriented to the continuous improvement which includes ICTs as one of its 
main pillars in order to reach the strategic goals of the organizations. Unlike other business 
management strategies, BPM offers capabilities and techniques which allow a flexible and dynamic 
management aligning strategic goals, the business processes which support it, and the technologies 
which allow it to be automatic [15]. In order to do so, BPM defines a life cycle which is made up of 
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the following stages: discovery, design, implementation, deployment, execution, interaction, control, 
monitoring, analysis, and optimization [16]. 
Associated to the BPM paradigm, there have arisen software platforms denominated BPM 
systems, which implement their whole cycle and offer a set of techniques and technologies that make 
those stages more dynamic. Each of these stages will have an important role in the redesign of the 
COPD management process, which will allow the identification of several weaknesses as duplicated 
tasks, activities with no value for the patient, over-bureaucratized tasks or bottlenecks inside the same 
process. 
BPM applied to the clinical process studied shows a new approach to manage an innovative 
process from the current state of the clinical process in a specific moment, and being different from 
reengineering, which considers creating such improvement from the redefinition of the whole 
process. This new approach of the whole COPD clinical process provides a higher flexibility and 
agility to adapt to change. It enables the integration of the process information which is scattered in 
different systems. It lines up the goals inner to the process together with the strategic ones, and it 
enables a continuous improvement and efficiency thanks to decrease the cost of inefficient subtasks 
or activities, through process-centered technology. 
In this paper, we have made a matching of the BPM stages with the process followed for business 
process reengineering (Figure 1). 
 
Figure 1. BPM life cycle applied to COPD clinical process. 
4. COPD Clinical Process 
This section will deal with the discovery stage of the COPD clinical process and will have the 
goal of understanding and knowing thoroughly how such disease is currently managed (AS_IS 
process), what tasks are performed, who is responsible, and what roles are involved in them, in order 
to later analyze the weaknesses. This study is based on the analysis of different medical guidelines, 
both worldwide [3,17,18] and nationwide, that is, spanish guidelines [19,20]. 
From the study it is gathered that, although all the guidelines define a group of common tasks, 
each of them establishes a series of subtasks or specific procedures according to the environment 
where the implementation is developed (geographic location, primary care centers, hospitals, etc.), 
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which show a lack of a de facto standard. Besides, all these guidelines are presented as procedures 
(oriented to the development of the task itself) much more than as processes, which are centered in 
the patients and in how to add value to satisfy their needs. Given the lack of standardization and the 
heterogeneity in the implementation of the clinical process for the diagnosis and treatment of COPD 
in the different guidelines, in this study we have taken as a reference the management of the COPD 
clinical process in primary care centers from the Spanish public health system. 
The current COPD process involves several human teams participating in the different tasks, 
which implies the need of adequate coordination among them in order to avoid problems which 
could affect the patients. Initially, the process in primary care centers implies an initial clinical 
evaluation from doctors and the nurses. In this evaluation, they register in the clinical record those 
data associated to smoking and risk work exposure of the patient. If patients are under 45 years of 
age, they are asked about family records. Also, a check of visual suggestive symptoms and signs of 
the disease is performed. Once the evaluation is finished, one of the most conclusive tasks when 
detecting COPD, the spirometry, is performed generally by the medical staff, although there are 
exceptions. This test is registered in the medical record together with the degree of dyspnea and the 
disease stage. Also, a physical examination is performed in order to detect the presence of cyanosis, 
tachypnea, edemas and other symptoms. The nurse may perform complementary tests such as a 
spirometry with bronchodilator, a thoracic X-ray, a complete blood count, an ECG and a pulse 
oximetry. Once the medical staff confirm the disease, the nursing service will provide the patient 
with a document with recommendations for COPD. 
5. Problems and Weaknesses in the COPD Management Process 
Nowadays, the COPD clinical process in primary care centers has a large number of 
inefficiencies and weaknesses. Among the main problems detected is the economic cost of the clinical 
process of COPD [7,8]. A factor that affects the cost of treatment is the high percentage of visits to 
primary schools due to exacerbations (10%) [21], the high cost of medications [22], inaccurate 
diagnosis or an inadequate use of diagnosis tests such as spirometries [21]. Moreover the number of 
physicians who perform the spirometry test in each of the visits is really low [22], either because the 
device is not available, or because the health personnel do not know in depth all the techniques and 
treatments of the disease, limited to old protocols [23]. In fact, less than 30% of the primary care 
centers have personnel expert in the use and performance of the diagnostic test of spirometry [24]. 
This implies a second visit to carry out the test. It is also highlighted that in the same diagnosis, there 
is a lack of detection of symptoms of depression and anxiety in patients with COPD, which often 
leads to worsening and worse recovery of the patient, especially in exacerbation status [25]. Elevated 
exacerbations in patients suffering from COPD is another of the weaknesses detected. It is also 
significant that a high percentage of patients with COPD continue to smoke (37%) [22]. This shortage 
has repercussions on both economic costs due to hospitalization and labor costs in terms of days of 
work [8]. 
Furthermore, an aspect to be highlighted is the lack of standardization of the process as well as 
the inefficient coordination that often occurs between the different medical teams that treat each 
pathology individually and not as a single process for the patient [21,24,26]. Another important aspect 
is the lack of health education, self-help and patient involvement in decision-making [21]. Follow up 
in many other aspects associated with COPD that surround the patient, allow the disease to be 
controlled in an efficient way, being able to coordinate the various comorbidities that the patient 
could present among the different health areas. Thus, we see that insufficient attention is paid to the 
nutritional aspect in patients with COPD since there is no general guide in this regard [27]. There is 
also a low percentage (between 10%–15%) of communication of self-care guides [24]. 
As a result of this analysis, the process of diagnosis and treatment of COPD in the centers is 
shown in the following graph (Figure 2) of primary care following the guide of the process of care of 
COPD [28] identifying in which stages the detected deficiencies take place. 
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Figure 2. COPD clinical process with the detected weaknesses. 
6. Redesign Process 
Once the clinical process has been analyzed and its problems and weaknesses have been 
detected, we are going to describe the redesign and modeling the COPD diagnosis sub-process. It is 
in this sub-process where most deficiencies are produced, which implies an additional cost, as well 
as a patient’s lower satisfaction. The diagnosis sub-process comprises the patient’s clinical evaluation, 
the spirometry test, and other optional complementary tests. The redesign process starts with the 
definition of the goals for the diagnosis of COPD patients who have not been previously diagnosed. 
The goals are: 
• Reducing the number of the patient’s unnecessary visits. 
• Performing the spirometry test in 100% of the cases when patients may suffer from the disease. 
With this goal, we expect to always perform this basic test in order to determine COPD. 
• Registering the spirometry test and other complementary tests in the medical record. 
• Traceability of all the tasks involved and real time communication of these tasks, as well as 
registering the timing of each of them. 
In order to measure the degree in which the aforementioned goals are accomplished, we have 
defined a series of Key Performance Indicators (KPIs) which will help us to measure the different 
activities which form the diagnosis throughout the time (Table 1). The KPIs that we are going to keep 
in mind for each objective are shown in the following table: 
The redesign of the process shown in Figure 3 starts when the patient asks for an appointment. 
The information system generates a previous questionnaire to be completed by the patient. This 
questionnaire has simple but well-focused questions, and it allows detecting the possible cases of 
COPD patients in a generic way. The performance of a complete questionnaire allows us to know 
more accurately and therefore have more accurate information on the patient’s condition, saving time 
for the medical staff to re-evaluate the patient with the extra cost of patient care, in addition to being 
able to perform a more accurate diagnosis of the patient. 
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Table 1. KPIs for the redesign stage. 
Objetives KPI Time Units Details 
Reducing the number of 
the patient’s unnecessary 
visits 
Duplicated tests 6 months % Percentage of 
duplicate clinical tests 
Registering tests in 
medical record Clinical record 6 months % 
Percentage of clinical 
records not recorded 
Registering the 
spirometry test in 100% 
of the cases 
Spirometries not 




Traceability for all the 
tasks involved 
Tasks not 
performed 6 months Number (#) 
Number of tasks not 
perforemd 
Registering the timing of 
all the tasks involved 
Tasks timing 
recorded  6 months Number (#) 
Number of tasks in 
which its duration 
has not been recorded 
 
Figure 3. COPD clinical process redesign using BPMN. 
If the system is dealing with a possible case of COPD, it starts doing other tasks so that the visit 
is prepared with the adequate equipment and medical staff. This way, when the patient attends the 
medical appointment, the necessary tests are performed without waiting inside the medical office, or 
even without attending a second appointment to have the specific COPD tests performed. Therefore, 
these tasks will increase the patients’ satisfaction because time associated to formalities in the first 
medical appointment is reduced. Appointments regarding COPD issues usually take longer than 
average appointments, so it is necessary for the information system to look for an adequate time for 
such appointment and, once allocated, it is also necessary to inform the patient. This sub-process 
allows the patient to have the specific tests performed in order to guarantee a correct diagnosis, 
increasing again the patient’s satisfaction and avoiding possible cost due to failure in it. 
Meanwhile, once nursing staff have been notified by the information system of an appointment 
with a possible COPD patient, they plan the patient’s assistance. This sub-process involves a series 
of additional subtasks, such as finding a spirometer, and preparing additional equipment, such as 
tubes, nozzles, filters, and medical thermal paper, in case the spirometer is not digital. This subtask 
avoids the patient not having the test performed due to lack of equipment, saving the economic costs 
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associated to a second appointment, both in medical staff and in costs associated to travelling and 
increasing the patient’s satisfaction (Figure 3). 
As it has been said in [21], there is a high percentage of spirometries which are not registered for 
different reasons, which implies a second visit by the patient. The existence of a spirometer is, 
therefore, mandatory in the diagnosis process of COPD since it saves short-term economic costs for 
the health system. The calibration of the spirometer is a very important sub-task since a wrong result 
could give a serious result with respect to the health of the patient. 
A correct calibration means avoiding a second visit, saving costs and improving patient 
satisfaction. The spirometer test must be performed correctly based on standards that must be known 
to the nursing staff. Therefore, the update of techniques and spirometry management by the nursing 
staff is important since it would ensure that the process is correct and therefore there have been no 
errors that could mean a second visit (Figure 4). 
Once all the patient’s results have been analyzed, the disease will be confirmed, in which case 
the request for additional tests, such as blood tests, chest X-rays or the 6 min on the treadmill, which 
would be recorded in the same way in his medical record (Figure 4). This sub-task is a time saving 
process since the patient could leave the consultation with an appointment for the completion of these 
complementary tests and avoid having to perform again tests already performed in the specialized 
center. Finally, creating and communicating the patients’ medical report would help in their 
psychological and self-esteem aspect and, therefore, in the patients’ satisfaction as they and their 
families would know at all times about their health and actions to take from that moment onwards. 
Applying a unified and current self-care guide could highly reduce the number of exacerbations. 
 
Figure 4. Registration of clinical records and spirometries. 
7. Conclusions 
As a consequence of a higher human life expectancy, the advances in medicine and in medical 
treatments have achieved that a high percentage of people may live longer, turning potentially 
deadly diseases into chronic diseases. Currently, national health systems bear a higher economic and 
management load derived from these chronic diseases, which imply high health expenditure. 
The inefficiency problems in clinical processes of chronic diseases, and the lack of integration 
among medical staff, families and the process itself, are goals to be reached through the 
implementation of a BPM strategy. 
Our proposal has focused on the application of a BPM strategy to the COPD clinical process, 
proposing a comprehensive management framework which coordinates, globally, all the elements 
participating in the clinical process management of COPD. The main novelty of our approach consists 
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in the use of business processes, IT management strategies, and the techniques and tools provided by 
the BPM paradigm applied to the clinical processes of chronic diseases. This way, we can obtain a 
dynamic model which adapts to the patients’ needs during their disease. Part of this flexibility is due 
to the concept of process orchestration which easily allows, as a jigsaw puzzle, to replace some 
options with others. 
8. Next Steps and Future Research Lines 
We are currently working on the implementation of the proposed model with the support of 
BPMS Bonita © BPM. We are developing the architecture of the COPD clinical process shown in this 
paper, and the integration of the existing sub-processes with Bonita Open Solution. It is important to 
highlight the use of business management processes in the clinical process itself, which until now 
were only implemented in administrative tasks associated to the clinical process. 
During the implementation, and as a future research, we are going to develop the whole clinical 
process, and not only the diagnostic sub-process, which will enable the dynamic and automatic 
management of the complete clinical process. In addition, this research is considered to be a first step 
to obtain a global model which integrates all the clinical processes associated to COPD, from its 
diagnosis to its treatment and follow-up of the disease. 
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